Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Efficacy and safety of Ipragliflozin as an add-on therapy to sitagliptin and Metformin in Korean patients with inadequately controlled type 2 diabetes mellitus: a randomized controlled trial
Manufactured in USA facilities under pharmaceutical-grade standards for in vitro research applications only
Most of the studies in fact, all the studies that we've seen now where we use patient-reported outcomes, meaning how's your physical functioning, in the trials they all go up across the board
The best-performing variant, X(GD_L)i, hereafter referred to as X(GD) (sequence listed in Fig
US$ 23.17
US$ 20.90
US$ 21.70
